CN Stock MarketDetailed Quotes
600671 Hangzhou Tianmushan Pharmaceutical Enterprise
- 9.36
- -0.38-3.90%
Market Closed Dec 13 15:00 CST
1.14BMarket Cap-78.66P/E (TTM)
9.78High9.26Low10.08KlotVolume9.74Open9.74Pre Close9.60MTurnover0.83%Turnover RatioLossP/E (Static)121.78MShares12.4152wk High34.04P/B1.14BFloat Cap5.8552wk Low10.23Limit Up121.72MShs Float39.71Historical High9.25Limit Down5.34%Amplitude0.84Historical Low--Dividend TTM9.53Avg Price5.17KlotAsk--Div YieldTTM100Lot Size4.10KlotBid
Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 44.80%124.68M | 16.87%59.55M | 24.64%27.74M | 11.82%121.78M | 9.98%86.11M | -1.76%50.95M | -14.58%22.25M | -25.95%108.91M | -21.57%78.29M | -32.83%51.86M |
| Operating revenue | 44.80%124.68M | 16.87%59.55M | 24.64%27.74M | 11.82%121.78M | 9.98%86.11M | -1.76%50.95M | -14.58%22.25M | -25.95%108.91M | -21.57%78.29M | -32.83%51.86M |
| Other operating revenue | ---- | 1,618.51%207.84K | ---- | -72.69%256.91K | ---- | 1,942.96%12.09K | ---- | 80.85%940.84K | ---- | -99.68%592 |
| Total operating cost | 21.74%129.72M | 26.24%84.57M | 26.79%38.9M | 4.05%151.54M | -3.00%106.56M | -8.17%66.99M | -10.31%30.68M | -16.50%145.64M | -9.02%109.85M | -17.63%72.95M |
| Operating cost | 7.33%71.36M | 10.18%43.46M | 9.17%19.3M | 13.48%95.25M | 8.67%66.49M | -4.73%39.44M | -11.14%17.68M | -17.02%83.93M | -9.70%61.18M | -26.31%41.4M |
| Operating tax surcharges | 55.16%973.93K | 59.93%404.12K | 128.33%39.22K | 9.92%1.05M | 9.50%627.69K | 33.75%252.68K | -135.84%-138.46K | -23.58%954.95K | -19.51%573.23K | -8.30%188.92K |
| Operating expense | 103.01%4.46M | 35.63%4.55M | 10.87%2.09M | -59.35%2.47M | -64.25%2.2M | -21.93%3.36M | -15.84%1.88M | -76.63%6.07M | -62.23%6.15M | -61.08%4.3M |
| Administration expense | 48.90%47.41M | 54.09%31.79M | 65.03%16.04M | -1.18%45.16M | -13.68%31.84M | -12.43%20.63M | -2.67%9.72M | 22.46%45.7M | 24.34%36.88M | 39.90%23.56M |
| Financial expense | 8.96%5.41M | 28.85%4.26M | -6.84%1.43M | -3.67%7.13M | -0.32%4.97M | -3.36%3.31M | -5.17%1.53M | -0.03%7.4M | -3.97%4.98M | -2.15%3.42M |
| -Interest expense (Financial expense) | 13.30%5.3M | 27.24%4.22M | -1.36%1.55M | -2.96%7.19M | -5.42%4.68M | -2.97%3.32M | -3.48%1.57M | 0.72%7.4M | -2.98%4.94M | 0.78%3.42M |
| -Interest Income (Financial expense) | -929.14%-351.2K | -742.66%-262.49K | -78.62%-146.16K | -122.01%-112.77K | 17.70%-34.13K | -87.97%-31.15K | -220.83%-81.83K | 49.26%-50.79K | 5.69%-41.47K | 18.37%-16.57K |
| Research and development | -75.89%106.8K | 7,685.79%106.8K | ---- | -69.56%482.22K | 446.13%442.96K | -98.31%1.37K | -98.31%1.37K | 18.92%1.58M | -92.86%81.11K | -89.81%81.11K |
| Credit Impairment Loss | -152.68%-2.64M | -88.80%170.33K | --42.68K | 106.66%511.7K | 265.86%5.02M | 150.27%1.52M | ---- | -81.72%-7.68M | -169.16%-3.02M | -169.19%-3.03M |
| Asset Impairment Loss | 101.57%115.52K | 101.74%115.52K | 227.01%123.36K | 67.54%-8.87M | -3,736.63%-7.34M | -3,368.70%-6.63M | ---97.13K | -236.45%-27.33M | -117.33%-191.27K | -116.67%-191.27K |
| Other net revenue | 0.32%-2.26M | 112.46%578.95K | 96.31%249.37K | 76.43%-7.81M | 11.09%-2.27M | -64.47%-4.65M | -0.55%127.03K | -211.05%-33.15M | -328.65%-2.55M | -372.73%-2.83M |
| Invest income | 105.48%28.84K | --28.84K | ---- | -154.51%-525.93K | -2,131,745.03%-525.93K | ---- | ---- | --964.81K | ---24.67 | ---24.67 |
| -Including: Investment income associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---28.84K | ---- | ---- |
| Asset deal income | -323.94%-137.26K | ---- | ---- | --333.47K | --61.29K | --61.29K | ---- | ---- | ---- | ---- |
| Other revenue | -27.62%374.53K | -34.83%264.26K | -62.83%83.33K | -17.41%740.86K | -22.12%517.43K | 3.75%405.52K | 75.50%224.15K | -45.81%897.01K | -41.53%664.37K | -61.38%390.87K |
| Operating profit | 67.85%-7.31M | -18.18%-24.45M | -31.50%-10.92M | 46.24%-37.57M | 33.39%-22.72M | 13.50%-20.69M | -3.40%-8.3M | -83.89%-69.88M | -72.26%-34.11M | -131.69%-23.91M |
| Add:Non operating Income | 44.21%4.93M | 62.05%3.94M | -10.37%1.06M | -36.21%6.63M | -61.05%3.42M | -58.74%2.43M | -63.96%1.18M | -36.27%10.39M | -9.87%8.78M | -9.43%5.89M |
| Less:Non operating expense | -84.75%1.25M | -83.75%875.55K | -92.45%215.48K | -58.30%5.37M | -9.92%8.23M | -15.24%5.39M | 25.04%2.85M | 6.97%12.87M | 42.11%9.13M | 92.50%6.36M |
| Total profit | 86.82%-3.63M | 9.56%-21.38M | -0.99%-10.07M | 49.82%-36.31M | 20.13%-27.53M | 3.02%-23.64M | -41.82%-9.97M | -114.51%-72.37M | -109.05%-34.46M | -242.52%-24.38M |
| Less:Income tax cost | 116,334.46%133.27K | -2,180,288.39%-2.5M | --25.79K | 294.15%2.99M | -98.41%114.46 | -98.41%114.46 | ---- | 179.43%757.42K | 108.50%7.21K | 135.14%7.21K |
| Net profit | 86.34%-3.76M | 20.12%-18.89M | -1.25%-10.1M | 46.26%-39.3M | 20.14%-27.53M | 3.04%-23.64M | -41.82%-9.97M | -123.06%-73.12M | -110.17%-34.47M | -243.61%-24.39M |
| Net profit from continuing operation | 86.34%-3.76M | 20.12%-18.89M | -1.25%-10.1M | 41.40%-39.01M | 20.14%-27.53M | 3.04%-23.64M | -41.82%-9.97M | -103.07%-66.57M | -110.17%-34.47M | -243.61%-24.39M |
| Net income from discontinuing operating | ---- | ---- | ---- | 95.62%-286.98K | ---- | ---- | ---- | ---6.55M | ---- | ---- |
| Less:Minority Profit | 3.83%-65.52K | -73.74%-385.85K | 59.11%-375.68K | 81.80%-1.02M | 98.39%-68.13K | 92.91%-222.09K | 23.83%-918.77K | -88.13%-5.61M | -232.22%-4.22M | -230.69%-3.13M |
| Net profit of parent company owners | 86.54%-3.7M | 21.01%-18.5M | -7.37%-9.72M | 43.31%-38.28M | 9.22%-27.46M | -10.19%-23.42M | -55.41%-9.06M | -126.56%-67.52M | -99.92%-30.25M | -245.60%-21.26M |
| Earning per share | ||||||||||
| Basic earning per share | 86.56%-0.0303 | 21.01%-0.1519 | -7.26%-0.0798 | 43.31%-0.3143 | 9.22%-0.2255 | -10.20%-0.1923 | -55.65%-0.0744 | -131.00%-0.5544 | -100.00%-0.2484 | -245.54%-0.1745 |
| Diluted earning per share | 86.56%-0.0303 | 21.01%-0.1519 | -7.26%-0.0798 | 43.31%-0.3143 | 9.22%-0.2255 | -10.20%-0.1923 | -55.65%-0.0744 | -131.00%-0.5544 | -100.00%-0.2484 | -245.54%-0.1745 |
| Other composite income | ||||||||||
| Total composite income | 86.34%-3.76M | 20.12%-18.89M | -1.25%-10.1M | 46.26%-39.3M | 20.14%-27.53M | 3.04%-23.64M | -41.82%-9.97M | -123.06%-73.12M | -110.17%-34.47M | -243.61%-24.39M |
| Total composite income of parent company owners | 86.54%-3.7M | 21.01%-18.5M | -7.37%-9.72M | 43.31%-38.28M | 9.22%-27.46M | -10.19%-23.42M | -55.41%-9.06M | -126.56%-67.52M | -99.92%-30.25M | -245.60%-21.26M |
| Total composite income of minority owners | 3.83%-65.52K | -73.74%-385.85K | 59.11%-375.68K | 81.80%-1.02M | 98.39%-68.13K | 92.91%-222.09K | 23.83%-918.77K | -88.13%-5.61M | -232.22%-4.22M | -230.69%-3.13M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- |
| Auditor | -- | -- | -- | Unitai Zhenqing Certified Public Accountants (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
